» Articles » PMID: 28448905

Drug Use Generations and Patterns of Injection Drug Use: Birth Cohort Differences Among People Who Inject Drugs in Los Angeles and San Francisco, California

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2017 Apr 28
PMID 28448905
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: A robust literature documents generational trends in drug use. We examined the implications of changing national drug use patterns on drug injection histories of diverse people who inject drugs (PWID).

Methods: Drug use histories were collected from 776 active PWID in 2011-13. Using descriptive statistics, we examine drug use initiation by year and birth cohort (BC) differences in drug first injected. A multivariate linear regression model of time to injection initiation ([TTII] (year of first injection minus year of first illicit drug use) was developed to explore BC differences.

Results: The first drug injected by BC changed in tandem with national drug use trends with heroin declining from 77% for the pre-1960's BC to 58% for the 1960's BC before increasing to 71% for the 1990's BC. Multivariate linear regression modeling found that shorter TTII was associated with the 1980's/1990's BC (-3.50 years; 95% Confidence Interval [CI]=-0.79, -6.21) as compared to the 1970's BC. Longer TTII was associated with being female (1.65 years; 95% CI=0.40, 2.90), African American (1.69 years; 95% CI=0.43, 2.95), any substance use treatment prior to injection (4.22 years; 95% CI=2.65, 5.79), and prior non-injection use of drug that was first injected (3.29 years; 95% CI=2.19, 4.40).

Conclusion: National drug trends appear to influence injection drug use patterns. The prescription opiate drug era is associated with shorter TTII. Culturally competent, demographically and generationally-targeted prevention strategies to combat transitions to drug injection are needed to prevent or shorten upstream increases in risky drug use practices on a national level.

Citing Articles

Association between non-injection drug use and hepatitis C infection among HIV-negative men who have sex with men.

Zhao J, Green C, Markham C, Fujimoto K, Nyitray A, Hwang L BMC Infect Dis. 2024; 24(1):985.

PMID: 39285350 PMC: 11406739. DOI: 10.1186/s12879-024-09685-3.


Decrease in injection and rise in smoking and snorting of heroin and synthetic opioids, 2000-2021.

Karandinos G, Unick J, Ondocsin J, Holm N, Mars S, Montero F Drug Alcohol Depend. 2024; 263:111419.

PMID: 39216201 PMC: 11684856. DOI: 10.1016/j.drugalcdep.2024.111419.


Context and correlates of providing assistance with someone's first injection in the AIDS linked to the IntraVenous Experience cohort, Baltimore, MD.

Gicquelais R, Astemborski J, Werb D, Kirk G, Mehta S, Genberg B Drug Alcohol Depend. 2023; 250:110909.

PMID: 37517262 PMC: 10529208. DOI: 10.1016/j.drugalcdep.2023.110909.


Potency-Enhancing Synthetics in the Drug Overdose Epidemic: Xylazine ("Tranq"), Fentanyl, Methamphetamine, and the Displacement of Heroin in Philadelphia and Tijuana.

Montero F, Bourgois P, Friedman J J Illicit Econ Dev. 2023; 4(2):204-222.

PMID: 37009634 PMC: 10065983. DOI: 10.31389/jied.122.


A Pilot Study of Polysubstance Use Sequences across the Lifespan among Assiniboine and Sioux People Who Use Injection Drugs.

Anastario M, Firemoon P, Rodriguez A, Wade C, Prokosch C, Rink E Int J Environ Res Public Health. 2023; 20(1).

PMID: 36612865 PMC: 9819103. DOI: 10.3390/ijerph20010543.


References
1.
Mackesy-Amiti M, Donenberg G, Ouellet L . Prevalence of psychiatric disorders among young injection drug users. Drug Alcohol Depend. 2012; 124(1-2):70-8. PMC: 3350828. DOI: 10.1016/j.drugalcdep.2011.12.012. View

2.
Solomon S, Celentano D, Srikrishnan A, Vasudevan C, Anand S, Kumar M . Mortality among injection drug users in Chennai, India (2005-2008). AIDS. 2009; 23(8):997-1004. PMC: 2697391. DOI: 10.1097/QAD.0b013e32832a594e. View

3.
Golub A, Johnson B . A recent decline in cocaine use among youthful arrestees in Manhattan, 1987 through 1993. Am J Public Health. 1994; 84(8):1250-4. PMC: 1615470. DOI: 10.2105/ajph.84.8.1250. View

4.
Nelson P, Mathers B, Cowie B, Hagan H, Des Jarlais D, Horyniak D . Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378(9791):571-83. PMC: 3285467. DOI: 10.1016/S0140-6736(11)61097-0. View

5.
Khan M, Berger A, Hemberg J, ONeill A, Dyer T, Smyrk K . Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users. AIDS Behav. 2012; 17(3):1185-94. PMC: 3923515. DOI: 10.1007/s10461-012-0276-0. View